Bibliografía del artículo
1. Singapore Renal Registry. First report of the Singapore Renal Register 1997.
2. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. U.S. Renal Data System Annual Data Report: Atlas of End-Stage Renal Disease in the United States 2004.
3. Jones CA, Krolewski AS, Rogus J, et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 67:1684-91, 2005.
4. Ng DPK, Krolewski AS. Molecular genetic approaches for studying the etiology of diabetic nephropathy. Current Mol Med 5:511-27, 2005.
5. Ng DPK, Tai BC, Koh D, et al. Angiotensin-I converting enzyme insertion/deletion polymorphism and diabetic nephropathy: A meta-analysis of studies reported during 1994-2004 and comprising 14,727 subjects. Diabetologia 48:1008-16, 2005.
6. Arzu Ergen H, Hatemi H, Agachan B, et al. Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med 36:345-50, 2004.
7. Degirmenci I, Kebapci N, Basaran A, et al. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic subjects. Int J Clin Pract 59:1137-42, 2005.
8. Shestakova MV, Vikulova OK, Nosikov VV. Role of genetic factors and arterial hypertension in development and progression of diabetic nephropathy (DN) in type 1 diabetes mellitus. Diabetes 54(Suppl 1):A195, 2005.
9. Canani LH, Costa LA, Crispim D, et al. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of type 2 diabetes. Diabet Med 22:1167-72, 2005.
10. Wang Y, Ng MCY, So WY, et al. Prognostic effect of insertion/deletion polymorphism of the ACE gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. Diabetes Care 28:348-54, 2005.
11. Ng DPK, Placha G, Choo S, et al. A disease haplotype for advanced nephropathy in type 2 diabetes at the ACE locus. Diabetes 55:2660-63, 2006.
12. Whitehead A. Meta-analysis of controlled clinical trials. Chichester: John Wiley & Sons, pp. 197-213, 2002.
13. Fleiss JL. The statistical basis of meta-analysis. Statistical Methods in Medical Research 2:121-145, 1993.
14. Armitage P, Berry G. Statistical methods in medical research, 3rd ed. London: Blackwell, pp. 521, 1994.
15. Keavney B, McKenzie CA, Connell JMC, et al. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7:1745-51, 1998.
16. Navar LG. The intrarenal renin-angiotensin system in hypertension. Kidney Int 65:1522-32, 2004.
17. Ruster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17:2985-91, 2006.
18. Jacobsen PK, Tarnow L, Parving HH. Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy? Kidney Int 69:1293-95, 2006.